Payer

The funds come two years after the company scored a $1.15 billion investment.

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

Nomi Health appointed its first chief product officer, and Hims & Hers announced that its first chief medical officer has returned to the role.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.

The partners said the test kits will first be offered to Blue Cross employees before a broader rollout with Medicare Advantage members next year.

The startup offers access to advocates who can help family caregivers make plans or solve problems as well as a digital health platform.

Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.